|
⚲
|
| Keyboard |
| Takeda Pharmaceutical Co Ltd
✚
|
|
|---|---|
| CIK # | 0001395064 |
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| OVID Therapeutics Inc | 9.8 | ||
| Equillium Inc | 2.6 | ||
| Xilio Therapeutics Inc | 1.2 | ||
| Shattuck Labs Inc | 1.2 | ||
| Lyell Immunopharma Inc | 0.9 | ||
| American Well Corp | 0.5 | ||
| RANI Therapeutics Holdings Inc | 0.1 | ||
| Fluidigm Corp | 0.0 | ||
| Holdings by Sector ($M) |
|---|
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001395064] | |
| 3 | [0001395064] | |
| 4 | [0001395064] | |
| 6-K | [0001395064] | |
| SC 13D | [0001395064] | |
| SC 13G | [0001395064] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Ovid Therapeutics Inc OVID
Common Stock
|
2025-12-08 | Conversion | 1,250,000 | $0.00 | |
|
Ovid Therapeutics Inc OVID
Series A Convertible Preferred Stock · derivative
|
2025-12-08 | Conversion | 1,250 | $0.00 | |
|
Phathom Pharmaceuticals Inc PHAT
Common Stock
|
2024-01-24 | Sell | 3,703,703 | $8.10 | 29,999,994 |
|
Calithera Biosciences Inc CALA
Series A Convertible Preferred Stock · derivative
|
2023-04-17 | Other | 1,000,000 | ||
|
HilleVax Inc HLVX
Common Stock
|
2022-11-30 | Option exercise | 5,883,500 | $0.00 | |
|
HilleVax Inc HLVX
Warrant (Right to Buy) · derivative
|
2022-11-30 | Option exercise | 5,883,500 | $0.00 | |
|
Calithera Biosciences Inc CALA
Series A Convertible Preferred Stock · derivative
|
2022-07-01 | Other | 1,000,000 | $0.00 | |
|
Ovid Therapeutics Inc OVID
Common Stock
|
2022-07-01 | Other | 5,750,000 | $0.00 | |
|
Ovid Therapeutics Inc OVID
Common Stock
|
2022-07-01 | Other | 5,750,000 | $0.00 | |
|
Ovid Therapeutics Inc OVID
Series A Convertible Preferred Stock · derivative
|
2022-07-01 | Other | 1,250 | $0.00 | |
|
Ovid Therapeutics Inc OVID
Series A Convertible Preferred Stock · derivative
|
2022-07-01 | Other | 1,250 | $0.00 | |
|
Calithera Biosciences Inc CALA
Series A Convertible Preferred Stock · derivative
|
2022-07-01 | Other | 1,000,000 | $0.00 | |
|
Phathom Pharmaceuticals Inc PHAT
Common Stock
|
2022-03-14 | Option exercise | 7,359,304 | $0.00 | |
|
Phathom Pharmaceuticals Inc PHAT
Warrants · derivative
|
2022-03-14 | Option exercise | 7,359,304 | $0.00 | |
|
Phathom Pharmaceuticals Inc PHAT
Common Stock
|
2022-03-14 | Sell | 18 | $19.00 | 342 |
|
Day One Biopharmaceuticals Holding Co LLC DAWN
Common Stock
|
2021-12-08 | Sell | 110,338 | $18.03 | 1,989,394 |
|
Day One Biopharmaceuticals Holding Co LLC DAWN
Common Stock
|
2021-12-07 | Sell | 128,745 | $18.43 | 2,372,770 |
|
Day One Biopharmaceuticals Holding Co LLC DAWN
Common Stock
|
2021-12-07 | Sell | 58,190 | $19.50 | 1,134,705 |
|
Day One Biopharmaceuticals Holding Co LLC DAWN
Common Stock
|
2021-12-06 | Sell | 97,692 | $18.05 | 1,763,341 |
|
Day One Biopharmaceuticals Holding Co LLC DAWN
Common Stock
|
2021-12-03 | Sell | 12,517 | $18.47 | 231,189 |
| showing 20 of 89 most recent transactions | |||||